93 related articles for article (PubMed ID: 2010619)
21. Screening for chronic beryllium disease: one hurdle down, two to go.
Cullen MR
Am J Respir Crit Care Med; 2005 Jan; 171(1):3-4. PubMed ID: 15615889
[No Abstract] [Full Text] [Related]
22. Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
Weston A; Snyder J; McCanlies EC; Schuler CR; Andrew ME; Kreiss K; Demchuk E
Mutat Res; 2005 Dec; 592(1-2):68-78. PubMed ID: 16054169
[TBL] [Abstract][Full Text] [Related]
23. Detection of antibodies against Bordetella avium in turkeys by avidin-biotin enhancement of the enzyme-linked immunosorbent assay and the dot-immunobinding assay.
Tsai HJ; Saif YM
Avian Dis; 1991; 35(4):801-8. PubMed ID: 1838473
[TBL] [Abstract][Full Text] [Related]
24. A reverse (antibody capture) enzyme-linked immunosorbent assay for detection of antisperm antibodies in sera and genital tract secretions.
Shai S; Bar-Yoseph N; Peer E; Naot Y
Fertil Steril; 1990 Nov; 54(5):894-901. PubMed ID: 2226923
[TBL] [Abstract][Full Text] [Related]
25. [The application of reagents of a biotin-avidin system in detecting anti-acetylcholine receptor antibody].
Xiao BG
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):5-7, 61. PubMed ID: 2805982
[TBL] [Abstract][Full Text] [Related]
26. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
[No Abstract] [Full Text] [Related]
27. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
Stange AW; Furman FJ; Hilmas DE
Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
[TBL] [Abstract][Full Text] [Related]
28. Enzyme-linked immunosorbent assay (ELISA) for detecting IgM and IgE antibodies in human schistosomiasis.
Lunde MN; Ottesen EA
Am J Trop Med Hyg; 1980 Jan; 29(1):82-5. PubMed ID: 6986098
[TBL] [Abstract][Full Text] [Related]
29. Abolition of natural tolerance and the influence of the chemical allergen beryllium on autoimmune processes.
Alekseeva OG; Vasil'eva EV; Orlova AA
Bull World Health Organ; 1974; 51(1):51-8. PubMed ID: 4549042
[TBL] [Abstract][Full Text] [Related]
30. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
Newman LS; Kreiss K
Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
[TBL] [Abstract][Full Text] [Related]
31. Significance of the blood beryllium lymphocyte proliferation test.
Newman LS
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
[TBL] [Abstract][Full Text] [Related]
32. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk.
Newman LS; Mroz MM; Balkissoon R; Maier LA
Am J Respir Crit Care Med; 2005 Jan; 171(1):54-60. PubMed ID: 15374840
[TBL] [Abstract][Full Text] [Related]
33. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
[TBL] [Abstract][Full Text] [Related]
34. Clinical application of beryllium lymphocyte proliferation testing.
Barna BP; Culver DA; Yen-Lieberman B; Dweik RA; Thomassen MJ
Clin Diagn Lab Immunol; 2003 Nov; 10(6):990-4. PubMed ID: 14607857
[No Abstract] [Full Text] [Related]
35. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis.
Chou YK; Edwards DM; Weinberg AD; Vandenbark AA; Kotzin BL; Fontenot AP; Burrows GG
J Immunol; 2005 Apr; 174(7):4316-24. PubMed ID: 15778396
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of beryllium sensitization and disease in nuclear workers.
Kreiss K; Mroz MM; Zhen B; Martyny JW; Newman LS
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):985-91. PubMed ID: 8214955
[TBL] [Abstract][Full Text] [Related]
37. Hygienic and toxicological aspects of occupational and environmental exposure to beryllium.
Bencko V; Vasil'eva EV
J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):403-17. PubMed ID: 6663073
[TBL] [Abstract][Full Text] [Related]
38. [Differential diagnosis of berylliosis/sarcoidosis in a dental technician].
Müller-Quernheim J; Zissel G; Schopf R; Vollmer E; Schlaak M
Dtsch Med Wochenschr; 1996 Nov; 121(47):1462-6. PubMed ID: 8983896
[TBL] [Abstract][Full Text] [Related]
39. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
[TBL] [Abstract][Full Text] [Related]
40. A study of immunological indices for diagnosis of chronic berylliosis.
Yao JJ; Hu SY
Biomed Environ Sci; 1989 Dec; 2(4):318-24. PubMed ID: 2604898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
